VDAC1 and cancer: Within the mitochondria, a promising anti-cancer target is the HKII (type II hexokinase)-VDAC (voltage dependent anion channel)-ANT (adenine nucleotide translocase) complex that spans the outer- and inner-mitochondrial membrane [39].